Cancer Database Query Results

CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.


Scientific Papers found: Click to Expand⟱
5278- 3BP,    The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression
- in-vitro, CRC, HCT116 - in-vitro, CRC, Caco-2 - in-vitro, CRC, SW48
ATP↓, TumCD↑, selectivity↑, toxicity↓, OS↑, HK2?, Cyt‑c↑, eff↑, p‑Akt↑,
5263- 3BP,  CET,    3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis
- in-vitro, CRC, DLD1 - NA, NA, HCT116
Synergy↑, Ferroptosis↓, TumAuto↑, Apoptosis↑, FOXO3↑, AMPKα↑, p‑Beclin-1/ATG6↑, HK2↓, ATP↓, ROS↑, Dose↝, TumVol↓, TumW↓, xCT/SLC7A11↑, GSH↓, eff↓, MDA↑,
4774- 5-FU,  TQ,  CoQ10,    Exploring potential additive effects of 5-fluorouracil, thymoquinone, and coenzyme Q10 triple therapy on colon cancer cells in relation to glycolysis and redox status modulation
- in-vitro, CRC, NA
AntiCan↑, TumCCA↑, Apoptosis↑, eff↑, Bcl-2↓, survivin↓, P21↑, p27/CDKN1B↑, BAX↑, Cyt‑c↑, Casp3↑, PI3K↓, Akt↓, mTOR↓, Hif1a↓, PTEN↑, AMPKα↑, PDH↑, LDHA↓, antiOx↓, ROS↑, AntiCan↑,
9258- Acai, EO,    Açaí Berries Inhibit Colon Tumorigenesis in Azoxymethane/Dextran Sulfate Sodium-Treated Mice
- in-vivo, CRC, NA
Risk↓, *MPO↓, *TNF-α↓, *IL1β↓, *IL6↓, *PCNA↓, *Bcl-2↓, *cl‑Casp3↓, *COX2/PTGS2?,
9257- Acai, EO,    Açai (Euterpe oleracea Mart.) feeding attenuates dimethylhydrazine-induced rat colon carcinogenesis
- in-vivo, CRC, NA
Dose↝, eff↑, TumNum↓, Ki-67↓,
9256- Acai, EO,    Pro-apoptotic activities of polyphenolics from açai (Euterpe oleracea Martius) in human SW-480 colon cancer cells
- in-vitro, CRC, HT-29 - in-vitro, Colon, SW480
TumCG↓, *toxicity↓, selectivity↑, ROS↓, NF-kB↓, ICAM-1↓, VCAM-1↓, Sp1/3/4↓, Bcl-2↓, VEGF↓, survivin↓, cl‑Cyt‑c↑, cl‑Casp3↑, PARP1↓,
5469- AF,    Ligand supplementation restores the cancer therapy efficacy of the antirheumatic drug auranofin from serum inactivation
- in-vitro, CRC, HCT116
Synergy↑, Half-Life↑,
944- AG,    Astragalus saponins inhibit cell growth, aerobic glycolysis and attenuate the inflammatory response in a DSS-induced colitis model
- vitro+vivo, CRC, NA
Glycolysis↓, lactateProd↓, TumCG↓,
5428- AG,    Meta-Analysis of Astragalus-Containing Traditional Chinese Medicine Combined With Chemotherapy for Colorectal Cancer: Efficacy and Safety to Tumor Response
- Review, CRC, NA
ChemoSen↑, chemoP↑, QoL↑, RenoP∅, hepatoP∅,
4561- AgNPs,  VitC,    Cellular Effects Nanosilver on Cancer and Non-cancer Cells: Potential Environmental and Human Health Impacts
- in-vitro, CRC, HCT116 - in-vitro, Nor, HEK293
NRF2↑, TumCCA↑, ROS↑, selectivity↑, *AntiViral↑, *toxicity↝, ETC↓, MMP↓, DNAdam↑, Apoptosis↑, lipid-P↑, other↝, UPR↑, *GRP78/BiP↑, *p‑PERK↑, *cl‑eIF2α↑, *CHOP/DDIT3↑, *JNK↑, Hif1a↓, AntiCan↑, *toxicity↓, eff↑,
4559- AgNPs,    Anticancer activity of biogenerated silver nanoparticles: an integrated proteomic investigation
- in-vitro, BC, SkBr3 - in-vitro, CRC, HT-29 - in-vitro, CRC, HCT116 - in-vitro, Colon, Caco-2
MMP2↓, MMP9↓, ROS↑, TumAuto↑, Apoptosis↑, ER Stress↑,
4557- AgNPs,    The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells
- in-vitro, NA, NIH-3T3 - in-vitro, CRC, HCT116
Cyt‑c↑, ROS↑, JNK↑,
5143- AgNPs,    Thermal Co-reduction engineered silver nanoparticles induce oxidative cell damage in human colon cancer cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis
- in-vitro, CRC, HCT116
ROS↑, lipid-P↑, GSH↓, MMP↓, Casp3↑, Apoptosis↑, TumCCA↑,
5142- AgNPs,    Biosynthesized Protein-Capped Silver Nanoparticles Induce ROS-Dependent Proapoptotic Signals and Prosurvival Autophagy in Cancer Cells
- in-vitro, CRC, HUH7
ROS↑, Apoptosis↑, eff↑, ChemoSen↑, EPR↑, Casp↑, MAPK↑,
4403- AgNPs,    Silver Nanoparticles Decorated UiO-66-NH2 Metal-Organic Framework for Combination Therapy in Cancer Treatment
- in-vitro, GBM, U251 - in-vitro, GBM, U87MG - in-vitro, GBM, GL26 - in-vitro, Cerv, HeLa - in-vitro, CRC, RKO
AntiCan↑, eff↑, EPR↑, selectivity↑, ROS↑, Casp↑, Apoptosis↑, DNAdam↑, tumCV↓, eff↑,
4412- AgNPs,    Biosynthesis and characterization of silver nanoparticles from Asplenium dalhousiae and their potential biological properties
- in-vitro, CRC, HCT116 - in-vitro, Melanoma, A2780S
Bacteria↓, antiOx↑, AntiCan↑, eff↑,
4362- AgNPs,    Enhancing Colorectal Cancer Radiation Therapy Efficacy using Silver Nanoprisms Decorated with Graphene as Radiosensitizers
- in-vitro, CRC, HCT116 - in-vitro, CRC, HT29 - in-vivo, NA, NA
eff↑, TumCG↓, OS↑, RadioS↑, eff↑, ROS↑, DNAdam↑, eff↝,
4379- AgNPs,    Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells
- in-vitro, CRC, LoVo
eff↑, TumCD↑, ROS↑, Bacteria↓,
340- AgNPs,    Screening bioactivities of Caesalpinia pulcherrima L. swartz and cytotoxicity of extract synthesized silver nanoparticles on HCT116 cell line
- in-vitro, CRC, HCT116
TumCD↑,
364- AgNPs,    Differential Action of Silver Nanoparticles on ABCB1 (MDR1) and ABCC1 (MRP1) Activity in Mammalian Cell Lines
- in-vitro, Lung, A549 - in-vitro, Hepat, HepG2 - in-vitro, CRC, SW-620
TumCD↑,
399- AgNPs,  SIL,    Cytotoxic potentials of silibinin assisted silver nanoparticles on human colorectal HT-29 cancer cells
- in-vitro, CRC, HT-29
P53↑,
9218- AITC,    Allyl-isothiocyanate against colorectal cancer via the mutual dependent regulation of p21 and Nrf2
- vitro+vivo, CRC, HCT116
TumCG↓, P21↑, NRF2↑, eff↓,
9219- AITC,    Sensitivity of allyl isothiocyanate to induce apoptosis via ER stress and the mitochondrial pathway upon ROS production in colorectal adenocarcinoma cells
- in-vitro, CRC, HT-29
TumCG↓, TumNum↓, tumCV↓, TumCCA↑, Casp9↑, Casp3↑, MMP↓, Cyt‑c↑, AIF↑, Endon↑, Ca+2↝, ER Stress↑, Cal1↑, ATF6↑, GRP78/BiP↑, GRP94↑, CHOP/DDIT3↑, CASP4↑, ROS↑,
5167- AL,    The Effects of Allicin, a Reactive Sulfur Species from Garlic, on a Selection of Mammalian Cell Lines
- in-vitro, Nor, 3T3 - in-vitro, BC, MCF7 - in-vitro, Lung, A549 - in-vitro, CRC, HT-29
Thiols↓, tumCV↓, TumCP↓, GSH↓, GSSG↑, ROS↑,
2668- AL,  Rad,    Allicin enhances the radiosensitivity of colorectal cancer cells via inhibition of NF-κB signaling pathway
- in-vitro, CRC, HCT116
RadioS↑, NF-kB↓,
1009- And,  5-FU,    Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of β-catenin/Wnt-signaling pathways in colorectal cancer
- in-vivo, CRC, HCT116 - in-vitro, CRC, SW480
ChemoSen↑, Casp9↑, Ferroptosis↑, Wnt/(β-catenin)↓, FTL↑, TP53↑, ACSL5↑, GCLC↑, GCLM↑, SAT1↑, STEAP3↑, ACSL5↑,
1351- And,  MLT,    Impact of Andrographolide and Melatonin Combinatorial Drug Therapy on Metastatic Colon Cancer Cells and Organoids
- in-vitro, CRC, T84 - in-vitro, CRC, COLO205 - in-vitro, CRC, HT-29 - in-vitro, CRC, DLD1
eff↑, Ki-67↓, Casp3↑, ER Stress↑, ROS↑, BAX↑, XBP-1↑, CHOP/DDIT3↑, eff↑,
1294- And,  5-FU,    Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression
- in-vitro, CRC, HCT116
Apoptosis↑, BAX↑,
1552- Api,    Apigenin inhibits the growth of colorectal cancer through down-regulation of E2F1/3 by miRNA-215-5p
- in-vitro, CRC, HCT116
Apoptosis↑, TumCP↓, miR-215-5p↑, TumCCA↑, E2Fs↓,
1541- Api,  EGCG,    Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence
- Human, CRC, NA
OS↑, Remission↓, Dose∅,
1008- Api,    Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling
- in-vitro, CRC, HCT116 - in-vitro, CRC, SW480
Wnt/(β-catenin)↓, β-catenin/ZEB1↓, TumAuto↑, Akt↓, mTOR↓, tumCV↓, TumCCA↑, TumAuto↑, p‑Akt↓, p‑p70S6↓, p‑4E-BP1↓,
578- Api,  Cisplatin,    Apigenin enhances the cisplatin cytotoxic effect through p53-modulated apoptosis
- in-vitro, Lung, A549 - in-vitro, BC, MCF7 - in-vitro, CRC, HCT116 - in-vitro, Pca, HeLa - in-vitro, Lung, H1299
p‑P53↑,
206- Api,    Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress
- in-vitro, Lung, H1299 - in-vitro, Lung, H460 - in-vitro, Lung, A549 - in-vitro, CRC, HCT116 - in-vitro, Melanoma, A375 - in-vitro, Lung, H2030 - in-vitro, CRC, SW480
Glycolysis↓, lactateProd↓, PGK1↓, ALDOA↓, GLUT1↓, ENO1↓, ATP↓, Casp9↑, Casp3↑, cl‑PARP↑, PI3K/Akt↓, HK1↓, HK2↓, ROS↑, Apoptosis↑, eff↓, NADPH↓, PPP↓,
172- Api,    Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/β-catenin signaling pathway
- in-vitro, CRC, SW480 - in-vitro, CRC, HTC15
Wnt/(β-catenin)↓, TCF↓, LEF1↓, TumCP↓, TumCMig↓, TumCI↓,
174- Api,    Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells
- in-vitro, CRC, SW480 - in-vitro, CRC, DLD1
NEDD9↓, TumCMig↓, TumCI↓,
175- Api,    Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT
- vitro+vivo, CRC, SW480 - vitro+vivo, CRC, DLD1 - vitro+vivo, CRC, LS174T
MMP↓, p‑Akt↓, TumCP↓, TumCI↓, NADH↓, HSP90↓, other↑, talin?,
2634- Api,    Apigenin induces both intrinsic and extrinsic pathways of apoptosis in human colon carcinoma HCT-116 cells
- in-vitro, CRC, HCT116
TumCG↓, TumCCA↑, MMP↓, ROS↑, Ca+2↑, ER Stress↑, mtDam↑, CHOP/DDIT3↑, DR5↑, cl‑BID↑, BAX↑, Cyt‑c↑, cl‑Casp3↑, cl‑Casp8↑, cl‑Casp9↑, Apoptosis↑,
2316- Api,    The interaction between apigenin and PKM2 restrains progression of colorectal cancer
- in-vitro, CRC, LS174T - in-vitro, CRC, HCT8 - in-vivo, CRC, NA
TumCP↓, PKM2↓, Glycolysis↓, TumCG↑, selectivity↑,
2573- ART/DHA,    Cell death mechanisms induced by synergistic effects of halofuginone and artemisinin in colorectal cancer cells
- in-vitro, CRC, HCT116
Synergy↑,
2582- ART/DHA,  5-ALA,    Mechanistic Investigation of the Specific Anticancer Property of Artemisinin and Its Combination with Aminolevulinic Acid for Enhanced Anticolorectal Cancer Activity
- in-vivo, CRC, HCT116 - in-vitro, CRC, HCT116
Synergy↑, ROS↑, selectivity↑, TumCG↓, toxicity↓,
5381- ART/DHA,    Artemisitene triggers calcium-dependent ferroptosis by disrupting the LSH-EWSR1 interaction in colorectal cancer
- in-vitro, CRC, HCT116 - in-vitro, Nor, NCM460 - in-vitro, CRC, HT29 - in-vitro, CRC, HCT8
Ferroptosis↑, CYP24A1↓, Ca+2↑, SCD1↓, FAO↑, lipid-P↑, eff↑, selectivity↑, other?,
5376- ART/DHA,    Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis
- in-vitro, CRC, HCT116 - in-vitro, CRC, HT29 - in-vitro, CRC, SW48 - in-vitro, BC, MDA-MB-453
Ferroptosis↑, Ferritin↓, Iron↑, eff↑, TumAuto↑, LC3II↑, ROS↑,
563- ART/DHA,    Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10
- in-vitro, Colon, colon26 - in-vitro, CRC, RKO
TGF-β↓, IL10↓,
5403- ASA,    Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer
- Trial, CRC, NA
Risk↓, other↝,
5410- ASA,    Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study
- Study, CRC, NA
Risk↓, Dose↝, Risk↓,
5404- ASA,    Low-Dose Aspirin and Prevention of Colorectal Cancer: Evidence From a Nationwide Registry-Based Cohort in Norway
- Study, CRC, NA
Risk↓, other↝, Dose↝, Risk↓, other↓, other↝, KRAS↓, other↓, other↓,
5406- ASA,    Adjuvant aspirin therapy and colorectal cancer survival
- Trial, CRC, NA
Dose↝, OS∅,
5407- ASA,    Low-dose aspirin reduces the risk of colorectal cancer recurrence in patients with resected PI3K-altered localised disease, according to the ALASCCA trial.
- Trial, CRC, NA
Dose↝, Risk↓,
1304- ASA,    Aspirin Inhibits Colorectal Cancer via the TIGIT-BCL2-BAX pathway in T Cells
- in-vitro, CRC, NA - in-vivo, NA, NA
TumCP↓, Apoptosis↑, Bcl-2↓, BAX↑, IL10↓, LTA/TNF-β↓,
1356- Ash,    Withaferin A induces apoptosis by ROS-dependent mitochondrial dysfunction in human colorectal cancer cells
- in-vitro, CRC, HCT116
ROS↑, TumCCA↑, MMP↓, TumCG↓, Apoptosis↑, JNK↝,

Showing Research Papers: 1 to 50 of 542
Page 1 of 11 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 542

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA⇅, 1,   NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 7,   Catalase↓, 1,   Catalase↑, 4,   ENOX2↓, 1,   ENOX2↑, 1,   Fenton↑, 1,   GCLC↑, 1,   GCLM↑, 1,   GPx↑, 3,   GPx1↓, 1,   GPx4↓, 5,   GSH↓, 16,   GSH↑, 2,   GSH/GSSG↓, 1,   GSS↑, 1,   GSSG↑, 1,   GSTs↓, 2,   GSTs↝, 1,   H2O2↑, 1,   i-H2O2↑, 1,   HO-1↓, 3,   HO-1↑, 4,   Iron↓, 1,   Iron↑, 5,   lipid-P↓, 1,   lipid-P↑, 8,   MDA↓, 2,   MDA↑, 4,   MPO↓, 1,   NADH↓, 1,   NQO1↓, 1,   NRF2↓, 11,   NRF2↑, 9,   Prx↓, 1,   Prx6↑, 1,   ROS↓, 18,   ROS↑, 116,   ROS⇅, 4,   ROS↝, 1,   ROS∅, 1,   i-ROS↑, 1,   mt-ROS↓, 1,   mt-ROS↑, 6,   selenoP↓, 1,   SOD↓, 2,   SOD↑, 3,   SOD1↓, 1,   Thiols↓, 2,   TKT↓, 2,   Trx↓, 1,   Trx1↑, 1,   TrxR↓, 3,   TrxR1?, 1,   TrxR1↓, 1,   TrxR1↑, 1,   xCT/SLC7A11↓, 3,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1,   FTH1↓, 1,   FTL↑, 1,   IronCh↑, 1,   selm↑, 1,   STEAP3↓, 1,   STEAP3↑, 1,   TfR1/CD71↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↓, 1,   CDC2↓, 2,   CDC25↓, 3,   ETC↓, 2,   HSP60/HSPD1↓, 3,   mitResp↓, 2,   mitResp↑, 2,   mtDam↑, 12,   OCR↓, 1,   OCR↑, 1,   OXPHOS↓, 1,   OXPHOS↑, 2,   PDH↑, 2,   PGC-1α↑, 1,   PINK1↑, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   5LO↓, 2,   ACC↑, 1,   p‑ACC-α↑, 1,   ACSL1↓, 1,   ACSL5↑, 2,   ALAT↓, 1,   ALAT↑, 1,   ALDOA↓, 2,   AMPK↑, 8,   AMPK↝, 1,   p‑AMPK↑, 3,   ATP↓, 10,   ATP↑, 1,   ATP⇅, 1,   i-ATP↓, 1,   Buty↑, 2,   CAIX/CA9↓, 1,   CBS↑, 1,   CPT1A↓, 1,   ECAR↓, 2,   ENO1↓, 3,   FAO↓, 1,   FAO↑, 1,   FASN↓, 3,   FDG↓, 1,   GAPDH↓, 1,   glucose↓, 1,   glucose↑, 1,   GlucoseCon↓, 6,   Glycolysis↓, 22,   GSK‐3β↓, 2,   GSK‐3β↑, 1,   p‑GSK‐3β↓, 2,   HK1↓, 1,   HK2?, 1,   HK2↓, 8,   HMG-CoA↓, 1,   IDO1↓, 1,   lactateProd↓, 13,   LDHA↓, 7,   lipoGen↓, 1,   NAD↓, 1,   NAD↑, 1,   NADH:NAD↓, 1,   NADPH↓, 2,   PA↑, 1,   PDK1 / PDPK1↓, 3,   PDKs↓, 3,   PFK1↓, 1,   PGK1↓, 1,   PKM2↓, 15,   PKM2↑, 1,   PPP↓, 3,   Pyrim↓, 1,   Pyruv↓, 1,   p‑S6↓, 1,   SAT1↑, 1,   SCD1↓, 1,   SCFAs↑, 4,   SIRT1↓, 2,   TS↓, 2,   Warburg↓, 9,  

Cell Death(tgid=5) ⓘ

AIF↑, 3,   APAF1↑, 2,   Apoptosis?, 1,   Apoptosis↓, 4,   Apoptosis↑, 170,   mt-Apoptosis↑, 2,   p‑ASK1↑, 1,   BAD↑, 5,   p‑BAD↓, 1,   Bak↑, 3,   BAX↓, 1,   BAX↑, 64,   Bax:Bcl2↑, 12,   Bcl-2↓, 85,   Bcl-2↑, 1,   Bcl-xL↓, 17,   BID↑, 3,   cl‑BID↑, 1,   BIM↑, 2,   Casp↑, 14,   Casp1↑, 2,   cl‑Casp1↑, 1,   Casp12↝, 1,   Casp3↑, 77,   cl‑Casp3↑, 23,   CASP4↑, 2,   Casp6↑, 1,   Casp7↑, 12,   cl‑Casp7↑, 2,   Casp8↑, 17,   cl‑Casp8↑, 3,   Casp9↑, 51,   p‑Casp9↑, 1,   cl‑Casp9↑, 6,   cFLIP↓, 3,   Cyt‑c↓, 1,   Cyt‑c↑, 38,   cl‑Cyt‑c↑, 1,   DR5↑, 6,   Endon↑, 1,   Fas↓, 1,   Fas↑, 4,   FasL↓, 1,   FasL↑, 1,   Ferroptosis↓, 1,   Ferroptosis↑, 13,   cl‑GSDMD↑, 1,   cl‑GSDME↑, 1,   IAP1↓, 3,   ICD↑, 2,   iNOS↓, 5,   Mcl-1↓, 2,   MDM2↓, 4,   MEG3↑, 1,   MOMP↑, 1,   Necroptosis↑, 1,   necrosis↑, 4,   p38↓, 3,   p38↑, 6,   p‑p38↓, 1,   p‑p38↑, 1,   PUMA↑, 1,   PUMA↝, 1,   Pyro↑, 2,   survivin↓, 31,   TNFR 1↑, 2,   TRAIL↑, 2,   TumCD↓, 1,   TumCD↑, 19,   XIAP↓, 9,   YAP/TEAD↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 2,   Akt↓, 43,   Akt↑, 3,   Akt∅, 1,   p‑Akt↓, 20,   p‑Akt↑, 1,   AKT1↓, 4,   AMPKα↑, 3,   CaMKII ?, 1,   CREB↓, 1,   EF-1α↓, 1,   EGFR↓, 8,   p‑EGFR↓, 1,   ERK↓, 10,   ERK↑, 2,   ERK∅, 1,   p‑ERK↓, 4,   p‑ERK↑, 1,   FGFR4/CD334↓, 1,   GRB2↓, 1,   HCAR2↑, 2,   Hippo↓, 1,   IGFR↓, 1,   IKKα↓, 3,   IKKα↑, 1,   p‑IKKα↓, 1,   IR↓, 1,   JAK↓, 1,   JAK1?, 1,   p‑JAK1↓, 1,   JAK2↓, 1,   p‑JAK2↓, 2,   JNK↓, 2,   JNK↑, 7,   JNK↝, 1,   p‑JNK↓, 1,   p‑JNK↑, 2,   LIFR/CD118↓, 1,   MAPK↓, 5,   MAPK↑, 6,   MAPK↝, 1,   p‑MAPK↑, 1,   MEK↓, 2,   p‑MEK↓, 1,   mTOR↓, 22,   mTOR↑, 2,   mTOR↝, 1,   p‑mTOR↓, 3,   OR13G1?, 1,   p70S6↓, 2,   p‑p70S6↓, 1,   P70S6K↓, 1,   PDGFRA↓, 1,   PI3K?, 1,   PI3K↓, 28,   PI3K↝, 1,   p‑PI3K↓, 8,   PI3K/Akt↓, 2,   PKCδ↓, 1,   p‑PKCδ↓, 1,   PTEN↑, 5,   p‑Raf↓, 1,   RAS?, 1,   RAS↓, 1,   S6K↓, 1,   p‑S6K↓, 1,   Sp1/3/4↓, 4,   Src↓, 1,   STAT↓, 3,   p‑STAT↓, 1,   STAT3↓, 19,   p‑STAT3↓, 8,   i-STAT3↓, 1,   STAT4↑, 1,   TK1↓, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF2↓, 1,   ATF4↑, 3,   cJun↓, 1,   cMyc↓, 12,   COMP↓, 1,   DNMT1↓, 3,   DNMT3A↓, 2,   DNMTs↓, 2,   EZH2↓, 1,   FOXO1↑, 1,   FOXO3↓, 2,   FOXO3↑, 1,   ac‑H3↝, 1,   HATs↑, 1,   HDAC↓, 15,   HDAC2↓, 1,   HDAC4↓, 1,   KCNQ1OT1↓, 1,   miR-106b↓, 1,   miR-130a↓, 1,   miR-139-5p↑, 1,   miR-145↑, 1,   miR-149↑, 1,   miR-155↓, 2,   miR-17↓, 1,   miR-195↑, 1,   miR-200b↑, 2,   miR-200c↑, 1,   miR-21↓, 2,   miR-215-5p↑, 1,   miR-22↑, 1,   miR-221↓, 1,   miR-25-5p↑, 1,   miR-27a-3p↓, 2,   miR-27a-3p↑, 1,   miR-29b↑, 1,   miR-34a↑, 6,   miR-409-3p↑, 1,   miR-490↑, 1,   miR-497↑, 1,   Myc↓, 1,   NNMT↓, 1,   OCT4↓, 1,   other?, 2,   other↓, 6,   other↑, 5,   other↝, 15,   SOX2↓, 1,   SUV39H↓, 1,   SUZ12↓, 1,   TET3↑, 1,   TFAP2A↓, 1,   tumCV?, 2,   tumCV↓, 64,   tumCV↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 1,   CHOP/DDIT3↑, 9,   i-CRT↓, 1,   eIF2α↓, 1,   eIF2α↑, 4,   p‑eIF2α↑, 2,   ER Stress↑, 21,   GRP78/BiP↓, 2,   GRP78/BiP↑, 6,   GRP94↑, 1,   HSP27↓, 2,   HSP27↑, 1,   HSP70/HSPA5↓, 1,   HSP70/HSPA5↑, 1,   HSP70/HSPA5⇅, 1,   HSP90↓, 4,   HTRA↓, 2,   IRE1↓, 1,   IRE1↑, 1,   PDI↑, 1,   PERK↑, 4,   UPR↑, 4,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG5↑, 2,   Beclin-1/ATG6↑, 5,   Beclin-1/ATG6⇅, 1,   p‑Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3B↑, 2,   LC3II↑, 3,   LC3s↑, 1,   p62↓, 2,   p62↑, 3,   PARK2↑, 1,   SESN2↑, 1,   TumAuto↓, 1,   TumAuto↑, 18,  

DNA Damage & Repair(tgid=10) ⓘ

8-oxo-dG↑, 1,   ATM↑, 1,   DNAdam↓, 3,   DNAdam↑, 25,   ERCC1↓, 1,   NBR2↑, 1,   NHEJ↓, 1,   p16↑, 1,   P53?, 1,   P53↓, 2,   P53↑, 31,   p‑P53↑, 2,   ac‑P53↑, 1,   i-P53↓, 1,   PARP↓, 5,   PARP↑, 7,   p‑PARP↑, 1,   cl‑PARP↑, 34,   PARP1↓, 2,   cl‑PARP1↑, 2,   PCNA↓, 6,   Telomerase↓, 2,   TP53↑, 1,   γH2AX↑, 4,  

Cell Cycle & Senescence(tgid=11) ⓘ

CC(CDKs/cyclins)↓, 1,   CDK1↓, 2,   CDK1↑, 1,   CDK2↓, 6,   CDK2↑, 1,   CDK4↓, 11,   CDK4↑, 1,   CDK6↓, 3,   CDK8↓, 1,   CDKN2C/p18↑, 1,   cellSen↑, 1,   ChrCon↑, 1,   cycA1/CCNA1↓, 2,   cycA1/CCNA1↑, 2,   CycB/CCNB1↓, 2,   CycB/CCNB1↑, 3,   cycD1/CCND1↓, 40,   cycD1/CCND1↑, 2,   CycD3↓, 1,   cycE/CCNE↓, 5,   cycE/CCNE↑, 1,   E2Fs↓, 3,   Ki-67↓, 18,   Ki-67↑, 1,   mitA↑, 1,   P21↓, 2,   P21↑, 27,   p27/CDKN1B↑, 6,   p‑RB1↓, 3,   TumCCA?, 1,   TumCCA↓, 4,   TumCCA↑, 104,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   p‑4E-BP1↓, 1,   ALDH↓, 1,   ALDH1A1↓, 1,   AXIN1↓, 1,   AXIN1↑, 1,   BMI1↓, 2,   CD133↓, 5,   CD24↓, 1,   CDX2↓, 1,   CEBPB?, 1,   cFos↓, 2,   cMYB↓, 1,   CSCs↓, 19,   CSCs↑, 1,   CSCsMark↓, 1,   Diff↓, 1,   Diff↑, 1,   EP2↓, 1,   EP4/PTGER4↓, 1,   Gli1↓, 1,   HH↓, 4,   IGF-1↓, 2,   Ki-67↓, 18,   Ki-67↑, 1,   Let-7↑, 2,   LGR5↓, 2,   Nanog↓, 3,   NKD2↑, 2,   NOTCH↓, 2,   NOTCH1↓, 1,   NOTCH1↝, 1,   OGFr↑, 1,   p300↓, 1,   Shh↓, 1,   TOPflash↓, 2,   TOPflash↑, 1,   TumCG?, 3,   TumCG↓, 101,   TumCG↑, 1,   TumCP↓, 122,   TumCP↑, 5,   TumCP⇅, 1,   TumCP∅, 1,   Wnt↓, 15,   Wnt↝, 1,   Wnt/(β-catenin)↓, 6,  

Migration(tgid=13) ⓘ

AGRN↓, 2,   AP-1↓, 3,   AP-1↝, 1,   Ca+2↑, 10,   Ca+2↝, 2,   i-Ca+2↑, 1,   mt-Ca+2↑, 1,   Cal1↑, 1,   cal2↑, 1,   CCN2/CTGF↓, 1,   COL2A1↓, 1,   COL9A3↓, 1,   CTNNB1↓, 1,   E-cadherin↓, 4,   E-cadherin↑, 18,   EMT↓, 28,   EMT↑, 1,   FAK↓, 3,   p‑FAK↓, 2,   GP1BB↓, 1,   ITGB1↓, 1,   ITGB4↓, 1,   ITGB6↓, 1,   KRAS↓, 3,   LAMA5↓, 1,   LEF1↓, 1,   MALAT1↓, 1,   MET↑, 2,   MMP2↓, 17,   MMP7↓, 2,   MMP9↓, 24,   MMPs↓, 7,   N-cadherin↓, 14,   NEDD9↓, 1,   p‑pax↓, 1,   Rho↓, 1,   Slug↓, 5,   Smad1↓, 1,   SMAD2↓, 1,   p‑SMAD2↓, 1,   SMAD3↓, 1,   p‑SMAD3↓, 1,   SMAD4↑, 1,   Snail↓, 11,   talin?, 1,   TET1↑, 3,   TGF-β↓, 5,   TGF-β1↓, 1,   TIMP2↑, 1,   TumCA↓, 3,   TumCI?, 1,   TumCI↓, 43,   TumCMig↓, 59,   TumCMig↑, 1,   TumMeta↓, 24,   TumMeta↑, 1,   TumPF↓, 2,   Twist↓, 4,   Twist↑, 1,   TXNIP↑, 1,   uPA↓, 2,   UroPA↓, 1,   Vim↓, 12,   Vim↑, 2,   Zeb1↓, 4,   ZEB2↓, 1,   β-catenin/ZEB1↓, 35,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 14,   angioG↑, 2,   CD31/PECAM-1↓, 1,   E-sel↓, 2,   E-sel↑, 1,   ECM/TCF↓, 2,   Endoglin↑, 1,   HIF-1↓, 1,   Hif1a↓, 21,   Hif1a↝, 1,   Hypoxia↓, 1,   NO↓, 1,   VCAM-1↓, 1,   VEGF↓, 22,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 3,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 2,   EPR↑, 3,   GLUT1↓, 8,   IBI↑, 4,   MMP↓, 58,   MMP↑, 2,   MPT↑, 1,   SLC12A5↝, 1,   SMCT1↑, 1,   SMCT1∅, 1,   SVCT-2∅, 1,   TJ↑, 1,   TRPV1↑, 1,   ZO-1↓, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD4+↑, 3,   CD44↓, 5,   CD8+↑, 7,   cDC2↓, 1,   p‑cDC2↓, 1,   COX1↓, 1,   COX2/PTGS2↓, 22,   COX2/PTGS2↑, 1,   CXCR4↓, 5,   DCells↑, 1,   DR4↑, 1,   FOXP3↓, 1,   Gal-3↓, 2,   Gal1↑, 1,   HCAR2↑, 2,   HMGB1↓, 4,   i-HMGB1↓, 1,   ICAM-1↓, 3,   IFN-γ↓, 1,   IFN-γ↑, 3,   IL10↓, 3,   IL10↑, 1,   IL12↑, 1,   IL13↓, 1,   IL18↑, 1,   IL1β↓, 6,   IL2↓, 1,   IL4↓, 3,   IL4↑, 1,   IL6↓, 18,   IL6↑, 1,   IL8↓, 6,   Imm↑, 5,   Imm↝, 2,   INF-γ↝, 1,   Inflam↓, 23,   Inflam↑, 2,   LTA/TNF-β↓, 1,   MCP1/CCL2↓, 1,   MCT1↓, 1,   MIP2↓, 1,   mPGES-1↓, 1,   Neut↑, 2,   NF-kB↓, 43,   NF-kB↑, 1,   p‑NF-kB↓, 2,   p‑NF-kB↑, 2,   NK cell↑, 2,   p50↓, 1,   p65↓, 2,   p‑p65↓, 2,   PD-L1↓, 4,   PD-L1↑, 1,   PGE2↓, 7,   T-Cell↑, 3,   TCF↓, 4,   TCF7/TCF1↓, 1,   Th1 response?, 1,   TLR1↑, 2,   TLR2↑, 1,   TLR4↓, 3,   TLR4↑, 1,   TNF-α↓, 13,   TNF-α↑, 2,   Treg lymp↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↓, 1,   pH↓, 2,   pH↝, 1,   e-pH↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

ChE↓, 1,  

Protein Aggregation(tgid=19) ⓘ

PSEN2/PS-2↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↑, 2,   CYP11A1↓, 1,   CYP24A1↓, 1,   ERβ/ESR2↑, 1,   PPARα↝, 1,   PPARγ↓, 1,   PPARγ↑, 2,   VDR↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 6,   BioAv↑, 6,   BioAv↝, 4,   BioEnh↑, 2,   ChemoSen↓, 2,   ChemoSen↑, 63,   ChemoSen⇅, 1,   ChemoSen↝, 1,   ChemoSen∅, 1,   CYP1A1↓, 1,   CYP1B1↓, 1,   DDS↑, 1,   Dose?, 4,   Dose↓, 3,   Dose↑, 3,   Dose⇅, 1,   Dose↝, 69,   Dose∅, 4,   eff↓, 45,   eff↑, 55,   eff⇅, 1,   eff↝, 9,   eff∅, 2,   GSTP1/GSTπ↓, 1,   Half-Life↑, 3,   Half-Life↝, 2,   MRP↓, 2,   MRP1/ABCC1↓, 1,   MRP2↓, 1,   MRP5↓, 1,   P-gp/ABCB1↓, 2,   P450↝, 1,   RadioS↑, 17,   selectivity?, 1,   selectivity↓, 1,   selectivity↑, 59,   Synergy↑, 29,   TET2↓, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 1,   ALAT↓, 1,   ALAT↑, 1,   ALB↑, 1,   ALP↑, 1,   ascitic↓, 1,   AST↓, 1,   AST↑, 1,   BUN↓, 1,   CA19-9↓, 1,   CEA↓, 1,   creat↓, 1,   CRP↓, 1,   EGFR↓, 8,   p‑EGFR↓, 1,   EZH2↓, 1,   Ferritin↓, 1,   Hcy/homoC↓, 1,   IL6↓, 18,   IL6↑, 1,   KRAS↓, 3,   LDH↓, 1,   LDH↑, 2,   Myc↓, 1,   PC↑, 1,   PD-L1↓, 4,   PD-L1↑, 1,   Polyps↓, 2,   RBC↑, 2,   SUZ12↓, 1,   TF-Ag↓, 1,   TG/TAG↓, 1,   TP53↑, 1,   Tumccf↓, 1,   WBC↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AEs∅, 1,   AntiCan↑, 37,   AntiTum↑, 16,   APG↓, 2,   Appetite↑, 1,   chemoP↑, 10,   chemoPv↑, 11,   ChemoSideEff↓, 2,   cognitive↑, 1,   DCR↑, 1,   fatigue↓, 2,   FTO↑, 1,   hepatoP∅, 1,   Mucositis↓, 1,   neuroP↑, 1,   ORR∅, 1,   OS↑, 23,   OS∅, 2,   Pain↓, 1,   PFS↑, 2,   PFS∅, 1,   Pin1↓, 1,   QoL↑, 4,   QoL∅, 1,   radioP↑, 1,   Remission↓, 1,   RenoP∅, 1,   Risk↓, 35,   Risk↑, 1,   Risk↝, 1,   Risk∅, 1,   Sleep↑, 1,   Symptoms∅, 1,   toxicity↓, 10,   toxicity↝, 1,   toxicity∅, 1,   TumNum↓, 3,   TumVol↓, 30,   TumVol↑, 1,   TumVol⇅, 1,   TumW↓, 11,   TumW⇅, 1,   Weight↑, 1,   Weight∅, 2,   Wound Healing↓, 1,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 3,   Diar↓, 1,   GutMicro↓, 1,   GutMicro↑, 15,   GutMicro↝, 2,   Inf↓, 4,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↑, 1,   Ingr↝, 6,  
Total Targets: 794

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 3,   antiOx↑, 18,   Catalase↑, 6,   GPx↑, 4,   GSH↓, 1,   GSH↑, 2,   GSR↑, 1,   HO-1↑, 4,   lipid-P↓, 4,   MDA↓, 4,   MPO↓, 1,   NQO1↑, 1,   NRF2↑, 8,   Prx↑, 1,   ROS↓, 12,   ROS∅, 1,   SOD↑, 6,   TAC↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

mtDam↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ECAR∅, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 1,   Bcl-2↓, 1,   Casp1↓, 1,   Casp3↓, 1,   cl‑Casp3↓, 1,   Casp8↓, 1,   Casp9↓, 1,   iNOS↓, 1,   p‑p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↝, 1,   ERK↓, 1,   p‑ERK↑, 1,   JNK↑, 1,   p‑JNK↓, 1,   MAPK↓, 2,   MAPK↝, 1,   PI3K↓, 1,   STAT3↝, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 2,   other?, 1,   other↑, 1,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 1,   cl‑eIF2α↑, 1,   GRP78/BiP↑, 1,   p‑PERK↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNArepair↑, 2,   PCNA↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Diff↝, 1,   TumCG∅, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 1,   AP-1↓, 1,   MMP13↓, 1,   TGF-β↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

COX1↓, 1,   COX2/PTGS2?, 1,   COX2/PTGS2↓, 3,   IL10↓, 1,   IL1β↓, 3,   IL4↓, 1,   IL6↓, 4,   Inflam↓, 24,   NF-kB↓, 2,   NLRP3↓, 1,   PGE2↓, 2,   TNF-α↓, 4,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   TPH1↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 2,   BioAv↑, 2,   BioAv↝, 1,   Dose↝, 1,   eff↓, 1,   GSTA1↑, 1,   Half-Life↝, 2,  

Clinical Biomarkers(tgid=22) ⓘ

CEA↓, 1,   IL6↓, 4,   LDH↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 4,   AntiDiabetic↑, 2,   antiNeop↑, 1,   cardioP?, 1,   cardioP↑, 6,   chemoP↑, 2,   chemoPv↑, 1,   hepatoP↑, 3,   memory↑, 1,   neuroP↑, 6,   Obesity↓, 1,   radioP↑, 1,   RenoP↑, 2,   toxicity↓, 12,   toxicity↝, 2,   toxicity∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 3,   AntiFungal↑, 1,   AntiP↓, 1,   AntiViral↑, 4,   Bacteria↓, 1,   GutMicro↑, 4,  
Total Targets: 104

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:6  Cells:%  prod#:%  Target#:%  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page